Promoting vascular repair in the retina: Can stem/progenitor cells help?

Thao Le Phuong Trinh, Sergio Li Calzi, Lynn C. Shaw, Mervin Yoder, Maria B. Grant

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Since its first epidemic in the 1940s, retinopathy of prematurity (ROP) has been a challenging illness in neonatology. Higher than physiological oxygen levels impede the development of the immature retinal neuropil and vasculature. Current treatment regimens include cryotherapy, laser photocoagulation, and anti-VEGF agents. Unfortunately, none of these approaches can rescue the normal retinal vasculature, and each has significant safety concerns. The limitations of these approaches have led to new efforts to understand the pathological characteristics in each phase of ROP and to find a safer and more effective therapeutic approach. In the era of stem cell biology and with the need for new treatments for ROP, this review discusses the possible future use of unique populations of proangiogenic cells for therapeutic revascularization of the preterm retina.

Original languageEnglish (US)
Pages (from-to)113-122
Number of pages10
JournalEye and Brain
Volume8
DOIs
StatePublished - May 26 2016

Fingerprint

Retinopathy of Prematurity
Blood Vessels
Retina
Stem Cells
Neonatology
Cryotherapy
Neuropil
Light Coagulation
Therapeutics
Vascular Endothelial Growth Factor A
Cell Biology
Lasers
Oxygen
Safety
Population

Keywords

  • Cd34 cells
  • Endothelial colony-forming cells
  • Endothelial progenitor cells
  • Oxygen-induced retinopathy
  • Retinopathy of prematurity
  • Rop therapy

ASJC Scopus subject areas

  • Ophthalmology
  • Cellular and Molecular Neuroscience
  • Sensory Systems

Cite this

Promoting vascular repair in the retina : Can stem/progenitor cells help? / Trinh, Thao Le Phuong; Calzi, Sergio Li; Shaw, Lynn C.; Yoder, Mervin; Grant, Maria B.

In: Eye and Brain, Vol. 8, 26.05.2016, p. 113-122.

Research output: Contribution to journalReview article

Trinh, Thao Le Phuong ; Calzi, Sergio Li ; Shaw, Lynn C. ; Yoder, Mervin ; Grant, Maria B. / Promoting vascular repair in the retina : Can stem/progenitor cells help?. In: Eye and Brain. 2016 ; Vol. 8. pp. 113-122.
@article{0febb72008de41e9ba0dd8119942216a,
title = "Promoting vascular repair in the retina: Can stem/progenitor cells help?",
abstract = "Since its first epidemic in the 1940s, retinopathy of prematurity (ROP) has been a challenging illness in neonatology. Higher than physiological oxygen levels impede the development of the immature retinal neuropil and vasculature. Current treatment regimens include cryotherapy, laser photocoagulation, and anti-VEGF agents. Unfortunately, none of these approaches can rescue the normal retinal vasculature, and each has significant safety concerns. The limitations of these approaches have led to new efforts to understand the pathological characteristics in each phase of ROP and to find a safer and more effective therapeutic approach. In the era of stem cell biology and with the need for new treatments for ROP, this review discusses the possible future use of unique populations of proangiogenic cells for therapeutic revascularization of the preterm retina.",
keywords = "Cd34 cells, Endothelial colony-forming cells, Endothelial progenitor cells, Oxygen-induced retinopathy, Retinopathy of prematurity, Rop therapy",
author = "Trinh, {Thao Le Phuong} and Calzi, {Sergio Li} and Shaw, {Lynn C.} and Mervin Yoder and Grant, {Maria B.}",
year = "2016",
month = "5",
day = "26",
doi = "10.2147/EB.S94451",
language = "English (US)",
volume = "8",
pages = "113--122",
journal = "Eye and Brain",
issn = "1179-2744",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Promoting vascular repair in the retina

T2 - Can stem/progenitor cells help?

AU - Trinh, Thao Le Phuong

AU - Calzi, Sergio Li

AU - Shaw, Lynn C.

AU - Yoder, Mervin

AU - Grant, Maria B.

PY - 2016/5/26

Y1 - 2016/5/26

N2 - Since its first epidemic in the 1940s, retinopathy of prematurity (ROP) has been a challenging illness in neonatology. Higher than physiological oxygen levels impede the development of the immature retinal neuropil and vasculature. Current treatment regimens include cryotherapy, laser photocoagulation, and anti-VEGF agents. Unfortunately, none of these approaches can rescue the normal retinal vasculature, and each has significant safety concerns. The limitations of these approaches have led to new efforts to understand the pathological characteristics in each phase of ROP and to find a safer and more effective therapeutic approach. In the era of stem cell biology and with the need for new treatments for ROP, this review discusses the possible future use of unique populations of proangiogenic cells for therapeutic revascularization of the preterm retina.

AB - Since its first epidemic in the 1940s, retinopathy of prematurity (ROP) has been a challenging illness in neonatology. Higher than physiological oxygen levels impede the development of the immature retinal neuropil and vasculature. Current treatment regimens include cryotherapy, laser photocoagulation, and anti-VEGF agents. Unfortunately, none of these approaches can rescue the normal retinal vasculature, and each has significant safety concerns. The limitations of these approaches have led to new efforts to understand the pathological characteristics in each phase of ROP and to find a safer and more effective therapeutic approach. In the era of stem cell biology and with the need for new treatments for ROP, this review discusses the possible future use of unique populations of proangiogenic cells for therapeutic revascularization of the preterm retina.

KW - Cd34 cells

KW - Endothelial colony-forming cells

KW - Endothelial progenitor cells

KW - Oxygen-induced retinopathy

KW - Retinopathy of prematurity

KW - Rop therapy

UR - http://www.scopus.com/inward/record.url?scp=84978906161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978906161&partnerID=8YFLogxK

U2 - 10.2147/EB.S94451

DO - 10.2147/EB.S94451

M3 - Review article

AN - SCOPUS:84978906161

VL - 8

SP - 113

EP - 122

JO - Eye and Brain

JF - Eye and Brain

SN - 1179-2744

ER -